K-pop

Lee Mu-jin Makes a Fresh Start with Mound Media’s New Label ‘Question Mark’

Former contestant on JTBC’s “Singer Again” Recently Parted Ways with Former Agency

KIM HYUNSIK
2026-08-31 17:11:15
[Edaily Starin KIM HYUNSIK Reporter] Mound Media announced on the 31st that singer Lee Mu-jin will continue his activities with the newly established label Question Mark.
(Photo = E-Daily DB)
Mound Media operates several subsidiary labels, including Magic Strawberry Sound (home to artists such as So-yu and Ye-bit), Marummo (home to Lee Seung-yoon), and Authentic (home to Han Ro-ro).
Question Mark is a label established specifically to sign Lee Mu-jin. On the same day, Mound Media launched Question Mark’s official social media channels and officially announced the label’s establishment and Lee Mu-jin’s joining.
Mound Media stated, “The goal of Question Mark and Lee Mu-jin is to leave not only joy and fun but also a lasting impression and food for thought.”
Lee Mu-jin rose to fame after appearing on the JTBC music survival show “Singer Again,” which concluded in 2021, and went on to gain popularity with songs such as “Traffic Light,” “Episode,” and “Youth Comic.” Lee Mu-jin recently parted ways with his former agency, Big Planet Made Entertainment, claiming he had not received his royalties.

Economy

Corporation

IT·Science

Economy

Shifting from Short-Term to Medium- and Long-Term... Appeal of Commercial Paper as a Funding Source Plummets

Fluctuations in credit spreads serve as an indicator of investor sentiment and capital flows in the corporate bond market. “Credit Signal” provides an intuitive analysis of the market’s overall trends…
2026-10-23 17:57:04

Corporation

Jeong Yong-jin Starts by Replacing E-MART Co., Ltd.’s CEO… Appoints Entire Executive Team in Their 40s

Shinsegae Co.,Ltd Chairman Chung Yong-jin is returning to the forefront of management at E-MART Co., Ltd.(139480). Unlike in 2013, when he stepped down as a registered director and entrusted the busin…
2026-10-23 14:55:06

IT·Science

HANALL BIOPHARMA CO.,LTD’s ‘Batoclimab’ Receives First New Drug Approval in China Nine Years After Technology Export

“Batoclimab,” a treatment for autoimmune diseases developed by HANALL BIOPHARMA CO.,LTD(009420), has received new drug approval in China. This comes approximately nine years after the company licensed…
2026-10-23 21:05:02